Airborne nanomaterials are optimally suited to penetrate into the deep lung (where alveolar epithelial type II cells (AECII) serve as a reservoir of the virus), due to the distinguished physicochemical properties of such aerosols. Nanomedicine is actively pursuing ideas to deliver drugs, therapeutic proteins, and mRNAs by exploiting nanodevices for pulmonary delivery.